Role of Genomic Instability in Immunotherapy with Checkpoint Inhibitors.

Abstract

The use of immune checkpoint blockade in tumors with higher mutational load was associated with improved OS. Our results suggest that the evaluation of tumor genomes may be predictive of immunotherapy benefit.